2,084
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Procalcitonin in the diagnosis of early-onset neonatal infection in resource-limited settings

, , , , & | (Reviewing Editor) show all
Article: 1283085 | Received 03 Nov 2016, Accepted 12 Jan 2017, Published online: 07 Feb 2017

References

  • Afroza, S. (2006). Neonatal sepsis -a global problem: An overview. Mymensingh Medical Journal, 15, 108–114.
  • Altunhan, H., Annagür, A., Örs, R., & Mehmetoğlu, I. (2011). Procalcitonin measurement at 24 hours of age may be helpful in the prompt diagnosis of early-onset neonatal sepsis. International Journal of Infectious Diseases, 15, e854–e858.10.1016/j.ijid.2011.09.007
  • Assicot, M., Bohuon, C., Gendrel, D., Raymond, J., Carsin, H., & Guilbaud, J. (1993). High serum procalcitonin concentrations in patients with sepsis and infection. The Lancet, 341, 515–518.10.1016/0140-6736(93)90277-N
  • Baraff, L. J., Oslund, S. A., Schriger, D. L., et al. (1992). Probability of bacterial infections in febrile infants less than three months of age. The Pediatric Infectious Disease Journal, 11, 257–265.10.1097/00006454-199204000-00001
  • Bedford Russell, A. R., & Kumar, R. (2015). Early onset neonatal sepsis: Diagnostic dilemmas and practical management. Archives of Disease in Childhood-Fetal and Neonatal Edition, 100, F350–F354.10.1136/archdischild-2014-306193
  • Bekker, V., Bijlsma, M. W., van de Beek, D., Kuijpers, T. W., & van der Ende, A. (2014). Incidence of invasive group B streptococcal disease and pathogen genotype distribution in newborn babies in the Netherlands over 25 years: A nationwide surveillance study. The Lancet Infectious Diseases, 14, 1083–1089.10.1016/S1473-3099(14)70919-3
  • Blommendahl, J., Janas, M., Laine, S., Miettinen, A., & Ashorn, P. (2002). Comparison of procalcitonin with CRP and differential white blood cell count for diagnosis of culture-proven neonatal sepsis. Scandinavian Journal of Infectious Diseases, 34, 620–622.10.1080/00365540210147723
  • Carrol, E. D., & Thomson, A. P. (2002). Procalcitonin as a marker of sepsis. International Journal of Antimicrobial Agents, 20(1), 1–9.10.1016/S0924-8579(02)00047-X
  • Caughey, A. B., Robinson, J. N., & Norwitz, E. R. (2008). Contemporary diagnosis and management of preterm premature rupture of membranes. Obstetrics & Gynecology, 1, 11–22.
  • Chiesa, C., Panero, A., Rossi, N., Stegagno, M., De Giusti, M., & Pacifico, L. (1998). Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically III neonates. Clinical Infectious Diseases, 26, 664–672.10.1086/cid.1998.26.issue-3
  • Chiesa, C., Pellegrini, G., Panero, A., Osborn, J. F., Signore, F., Assumma, M., & Pacifico, L. (2003). C-reactive protein, interleukin-6, and procalcitonin in the immediate postnatal period: Influence of illness severity, risk status, antenatal and perinatal complications, and infection. Clinical Chemistry, 49, 60–68.10.1373/49.1.60
  • De, S., Williams, G. J., Hayen, A., Macaskill, P., McCaskill, M., Isaacs, D., & Craig, J. C. (2014). Value of white cell count in predicting serious bacterial infection in febrile children under 5 years of age. Archives of Disease in Childhood, 99, 493–499.10.1136/archdischild-2013-304754
  • Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., … Osborn, T. M. (2013). Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock. Critical Care Medicine, 41, 580–637.10.1097/CCM.0b013e31827e83af
  • Drain, P. K., Hyle, E. P., Noubary, F., Freedberg, K. A., Wilson, D., Bishai, W. R., … Bassett, I. V. (2014). Diagnostic point-of-care tests in resource-limited settings. The Lancet Infectious Diseases, 14, 239–249.10.1016/S1473-3099(13)70250-0
  • Gendrel, D., & Bohuon, C. (2000). Procalcitonin as a marker of bacterial infection. The Pediatric Infectious Disease Journal, 19, 679–688.10.1097/00006454-200008000-00001
  • Goldstein, B., Giroir, B., & Randolph, A. (2005). International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics. Pediatric Critical Care Medicine, 6, 2–8.10.1097/01.PCC.0000149131.72248.E6
  • Gray, J. W. (2007). Surveillance of infection in neonatal intensive care units. Early Human Development, 83, 157–163.10.1016/j.earlhumdev.2007.01.006
  • Hay Burgess, D. C., Wasserman, J., & Dahl, C. A. (2006). Global health diagnostics. Nature, 444, 1–2.10.1038/nature05440
  • Heath, P. T., Balfour, G., Weisner, A. M., Efstratiou, A., Lamagni, T. L., … McCartney, A. C. (2004). Group B streptococcal disease in UK and Irish infants younger than 90 days. The Lancet, 363, 292–294.10.1016/S0140-6736(03)15389-5
  • Hengst, J. M. (2003). The role of C-reactive protein in the evaluation and management of infants with suspected sepsis. Advances in Neonatal Care, 3, 3–13.10.1053/adnc.2003.50010
  • Hyde, T. B., Hilger, T. M., Reingold, A., Farley, M. M., O’Brien, K. L., & Schuchat, A. (2002). Trends in incidence and antimicrobial resistance of early-onset sepsis: Population-based surveillance in San Francisco and Atlanta. Pediatrics, 110, 690–695.10.1542/peds.110.4.690
  • Institute of Medicine and Forum on Microbial Threats. (2007). Global infectious disease surveillance and detection: assessing the challenges – finding solutions, workshop summary. Washington, DC: National Academies Press. Retrieved Jan 14, 2013, from http://www.nap.edu/catalog/11996.html
  • Lachenauer, C. S., & Wessels, M. R. (2011). Group B streptococcus. In Saunders. Nelson Textbook of Pediatrics (19th ed., Chapter 177, pp. 925–928). Philadelphia, PA: An Imprint of Elsevier.
  • Le Doare, K., Nichols, A.-L., Payne, H., Wells, R., Navidnia, S., Appleby, G., & Calton, E. (2014). Very low rates of culture-confirmed invasive bacterial infections in a prospective 3-year population-based surveillance in Southwest London. Archives of Disease in Childhood, 99, 526–531. doi:10.1136/archdischild2013-305565
  • López Sastre, J. B., Pérez Solís, D., Serradilla, V. R., Colomer, B. F., Coto Cotallo, G. D., & Grupo de Hospitales Castrillo. (2007). Procalcitonin for the diagnosis of neonatal sepsis of vertical transmission. BMC Pediatrics BMC series open, inclusive and trusted, 7.
  • Mabey, D., Peeling, R. W., & Perkins, M. D. (2001). Rapid and simple point-of-care diagnostics for STIs. Sexually Transmitted Infections, 77, 397–398.10.1136/sti.77.6.397
  • Mabey, D., Peeling, R. W., Ustianowski, A., & Perkins, M. D. (2004). Diagnostics for the developing world. Nature Reviews Microbiology, 2, 231–240.10.1038/nrmicro841
  • Ming, J., & AI, K. (2010). Procalcitonin: Uses in the clinical laboratory for the diagnosis of sepsis. Labmedicine, 41, 173–177.
  • Mirrett, S., Weinstein, M. P., Reimer, L. G., Wilson, M. L., & Reller, L. (2001). Relevance of the number of positive bottles in determining clinical significance of coagulase-negative staphylococci in blood cultures. Journal of Clinical Microbiology, 39, 3279–3281.10.1128/JCM.39.9.3279-3281.2001
  • Mukherjee, A., Ramalingaiah, B., Kennea, N., & Duffy, D. A. (2014). Management of neonatal early onset sepsis (CG149): compliance of neonatal units in the UK with NICE recommendations. Archives of Disease in Childhood-Fetal and Neonatal Edition. doi:10.1136/archdischild-2014-307776
  • NICE. (2012, August). Neonatal infection: Antibiotics for prevention and treatment. NICE Guidelines CG149.
  • Peeling, R. W., Holmes, K. K., Mabey, D., & Ronald, A. (2006). Rapid tests for sexually transmitted infections (STIs): The way forward. Sexually Transmitted Infections, 82, v1–v6.10.1136/sti.2006.024265
  • Peeling, R. W., Smith, P. G., & Bossuyt, P. M. (2006). A guide for diagnostic evaluations. Nature Reviews Microbiology, 4, S2–S6.10.1038/nrmicro1568
  • Polin, R. A. (2012). Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics, 129, 1006–1015.10.1542/peds.2012-0541
  • Ramirez, S. I. (2014). Procalcitonin: A reliable predictive biomarker to diagnose early –onset neonatal sepsis. Pediatrics, 1–6.
  • van Rossum, A. M. C., Wulkan, R. W., & Oudesluys-Murphy, A. M. (2004). Procalcitonin as an early marker of infection in neonates and children. The Lancet Infectious Diseases, 4, 620–630.10.1016/S1473-3099(04)01146-6
  • Shah, A. J., Mulla, S. A., & Revdiwala, S. B. (2012). Neonatal sepsis: High antibiotic resistance of the bacterial pathogens in a neonatal intensive care unit of a tertiary Care hospital. Journal of Clinical Neonatology, 1, 72–75.10.4103/2249-4847.96753
  • Simon, L., Gauvin, F., Amre, D. K., & Saint-Louis, P. (2004). Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: A systematic review and meta-analysis. Clinical Infectious Diseases, 39, 206–217.10.1086/421997
  • Stocker, M., Hop, W. C. J., & van Rossum, A. M. C. (2010). Neonatal procalcitonin intervention study (NeoPInS): Effect of procalcitonin-guided decision making on duration of antibiotic therapy in suspected neonatal early-onset sepsis: A multi-centre randomized superiority and non-inferiority intervention study. BMC Pediatrics, 10, 261.10.1186/1471-2431-10-89
  • Stoll, B. (2011). Infections of the neonatal infant. Saunders. Nelson Textbook of Pediatrics (19th ed., Chapter 103, pp. 629–648). An Imprint of Elsevier.
  • Tripathi, N., Cotten, C. M., & Smith, P. B. (2012). Antibiotic use and misuse in the neonatal intensive care unit. Clinics in Perinatology, 39, 61–68.10.1016/j.clp.2011.12.003
  • Urdea, M., Penny, L. A., Olmsted, S. S., Giovanni, M. Y., Kaspar, P., Shepherd, A., … Burgess, D. C. H. (2006). Requirements for high impact diagnostics in the developing world. Nature, 444, 73–79.10.1038/nature05448
  • Vergnano, S., Sharland, M., Kazembe, P., Mwansambo, C., & Heath, P. T. (2005). Neonatal sepsis: An international perspective. Archives of Disease in Childhood-Fetal and Neonatal Edition, 90, F220–F224.10.1136/adc.2002.022863
  • Vernet, G., Mary, C., Altmann, D. M., Doumbo, O., Morpeth, S., Bhutta, Z. A., & Klugman, K. P. (2014). Surveillance for antimicrobial drug resistance in under-resourced countries. Emerging Infectious Diseases, 20, 443–441.